Cevimeline hydrochloride hemihydrate
Cevimeline hydrochloride hemihydrate is a novel muscarinic receptor agonist, used as a candidate therapeutic drug for xerostomia in Sjogren’s syndrome.
| Catalog Number | T2390 |
| Research Area | Neuroscience |
| Molecular Formula | C20H38Cl2N2O3S2 |
| CAS# | 153504-70-2 |
| Purity | 100.00% |
| SMILES | O.Cl.Cl.C[C@@H]1O[C@]2(CS1)CN1CCC2CC1.C[C@@H]1O[C@]2(CS1)CN1CCC2CC1 |
| Size | 5 mg |
| Supplier Page | https://www.targetmol.com/compound/Cevimeline hydrochloride hemihydrate |
| Additional Information | https://www.targetmol.com/datasheet/T2390 |
